# Advisor Review - Advisor 1/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T18:56:44.810093
**Response ID:** resp_03dfd68dad469cef00697b9eb47034819592b5e4ec3600222c
**Tokens:** 19365 in / 5403 out
**Response SHA256:** 92ed812120b8c752

---

I checked the draft only for *fatal* issues in the four requested categories (data–design alignment, regression sanity, completeness, internal consistency). I did **not** find any fatal errors.

- **Data–design alignment:** Treatment cohorts run 2014–2024 and the main BFS application outcomes cover 2005–2024, so the design is feasible for all cohorts (even if some late cohorts have only 1–2 post years). The BF8Q outcome is correctly described as available only through 2020 and you explicitly flag why it cannot be interpreted causally under the DiD timing; that resolves the main potential alignment trap.
- **Regression sanity:** All reported coefficients, SEs, and R² values in Tables 3–6 are numerically plausible (no impossible R², no NA/Inf, no explosive SEs).
- **Completeness:** Regression tables report coefficients, SEs, and N; referenced figures/tables shown in the excerpt appear to exist; no placeholders observed.
- **Internal consistency:** Key numbers stated in the text/abstract (e.g., TWFE ≈ −0.068; CS ATT ≈ −0.028; RI p = 0.093; bootstrap p = 0.064; BF8Q caveat) match the corresponding tables/figures as presented.

ADVISOR VERDICT: PASS